Un fármaco podría ayudar a ralentizar la miopía en los niños
VIERNES, 2 de junio de 2023 (HealthDay News) — La miopía no tiene cura, pero unas gotas para los ojos medicadas pueden ralentizar su progresión en los niños, encuentra un nuevo ensayo. El estudio evaluó los efectos de unas gotas para los ojos que con…
Learn MoreChinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.The U.S. Food and Drug Administration is work…
Learn MoreChinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.The U.S. Food and Drug Administration is work…
Learn MoreOne Form of Menopause Hormone Therapy Might Raise Blood Pressure
MONDAY, June 5, 2023 (HealthDay News) — Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests.The study, of over 100,000 menopausal women…
Learn MoreOne Form of Menopause Hormone Therapy Might Raise Blood Pressure
MONDAY, June 5, 2023 (HealthDay News) — Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests.The study, of over 100,000 menopausal women…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreUltrasonography Noninferior to Radiography for Pediatric Distal Forearm Injury
MONDAY, June 5, 2023 (HealthDay News) — For children presenting to the emergency department with an isolated distal forearm injury, initial point-of-care ultrasonography is noninferior to radiography for physical function of the affected arm at four …
Learn MoreUltrasonography Noninferior to Radiography for Pediatric Distal Forearm Injury
MONDAY, June 5, 2023 (HealthDay News) — For children presenting to the emergency department with an isolated distal forearm injury, initial point-of-care ultrasonography is noninferior to radiography for physical function of the affected arm at four …
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn More